CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.
Saved in:
| Title: | CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification. |
|---|---|
| Authors: | Okoye AA; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Duell DD; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Fukazawa Y; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Varco-Merth B; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Marenco A; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Behrens H; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Chaunzwa M; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Selseth AN; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Gilbride RM; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Shao J; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Geleziunas R; Gilead Sciences, Inc., Foster City, California, USA., Pinkevych M; Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, New South Wales, Australia., Davenport MP; Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, New South Wales, Australia., Busman-Sahay K; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Nekorchuk M; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Park H; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Smedley J; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Axthelm MK; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Estes JD; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Hansen SG; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Picker LJ; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2021 Apr 15; Vol. 131 (8). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33630764 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Okoye+AA%22">Okoye AA</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Duell+DD%22">Duell DD</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Fukazawa+Y%22">Fukazawa Y</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Varco-Merth+B%22">Varco-Merth B</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Marenco+A%22">Marenco A</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Behrens+H%22">Behrens H</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Chaunzwa+M%22">Chaunzwa M</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Selseth+AN%22">Selseth AN</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Gilbride+RM%22">Gilbride RM</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Shao+J%22">Shao J</searchLink>; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Edlefsen+PT%22">Edlefsen PT</searchLink>; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Geleziunas+R%22">Geleziunas R</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Pinkevych+M%22">Pinkevych M</searchLink>; Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Davenport+MP%22">Davenport MP</searchLink>; Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Busman-Sahay+K%22">Busman-Sahay K</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Nekorchuk+M%22">Nekorchuk M</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Park+H%22">Park H</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Smedley+J%22">Smedley J</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Axthelm+MK%22">Axthelm MK</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Estes+JD%22">Estes JD</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Hansen+SG%22">Hansen SG</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Keele+BF%22">Keele BF</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Leidos Biomedical Research, Inc., Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Lifson+JD%22">Lifson JD</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Leidos Biomedical Research, Inc., Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Picker+LJ%22">Picker LJ</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2021 Apr 15; Vol. 131 (8). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33630764 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI141677 Languages: – Code: eng Text: English Titles: – TitleFull: CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Okoye AA – PersonEntity: Name: NameFull: Duell DD – PersonEntity: Name: NameFull: Fukazawa Y – PersonEntity: Name: NameFull: Varco-Merth B – PersonEntity: Name: NameFull: Marenco A – PersonEntity: Name: NameFull: Behrens H – PersonEntity: Name: NameFull: Chaunzwa M – PersonEntity: Name: NameFull: Selseth AN – PersonEntity: Name: NameFull: Gilbride RM – PersonEntity: Name: NameFull: Shao J – PersonEntity: Name: NameFull: Edlefsen PT – PersonEntity: Name: NameFull: Geleziunas R – PersonEntity: Name: NameFull: Pinkevych M – PersonEntity: Name: NameFull: Davenport MP – PersonEntity: Name: NameFull: Busman-Sahay K – PersonEntity: Name: NameFull: Nekorchuk M – PersonEntity: Name: NameFull: Park H – PersonEntity: Name: NameFull: Smedley J – PersonEntity: Name: NameFull: Axthelm MK – PersonEntity: Name: NameFull: Estes JD – PersonEntity: Name: NameFull: Hansen SG – PersonEntity: Name: NameFull: Keele BF – PersonEntity: Name: NameFull: Lifson JD – PersonEntity: Name: NameFull: Picker LJ IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 04 Text: 2021 Apr 15 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1558-8238 Numbering: – Type: volume Value: 131 – Type: issue Value: 8 Titles: – TitleFull: The Journal of clinical investigation Type: main |
| ResultId | 1 |